NCT03335072View on ClinicalTrials.gov

Kebele Elimination of Trachoma for Ocular Health

PHASE4Active, not recruitingINTERVENTIONAL

Enrollment

320,000

Participants

Timeline

Start Date

February 7, 2022

Primary Completion Date

March 1, 2027

Study Completion Date

March 1, 2028

Conditions

Trachoma

Interventions

DRUG

Azithromycin

Mass Drug Administration

Trial Locations (2)

94143

UCSF Proctor Foundation, San Francisco

Unknown

Eyu-Ethiopia, Bahir Dar

All Listed Sponsors

collaborator

National Eye Institute (NEI)

NIH

collaborator

Eyu-Ethiopia

UNKNOWN

collaborator

Bahir Dar University

OTHER

lead

University of California, San Francisco

OTHER